Literature DB >> 18283041

Epigenetic inactivation of protein kinase D1 in gastric cancer and its role in gastric cancer cell migration and invasion.

Mirang Kim1, Hay-Ran Jang, Jeong-Hwan Kim, Seung-Moo Noh, Kyu-Sang Song, June-Sik Cho, Hyun-Yong Jeong, Jim C Norman, Patrick T Caswell, Gyeong Hoon Kang, Seon-Young Kim, Hyang-Sook Yoo, Yong Sung Kim.   

Abstract

Protein kinase D (PKD) 1 influences cell migration by mediating both trans-Golgi vesicle fission and integrin recycling to the cell surface. Using restriction landmark genomic scanning methods, we found that the promoter region of PKD1 was aberrantly methylated in gastric cancer cell lines. Silencing of PKD1 expression was detected in 72.7% of gastric cancer cell lines examined, and the silencing was associated with CpG hypermethylation in the promoter region of PKD1. Treatment with 5-aza-2'-deoxycytidine and trichostatin A partially reversed PKD1 methylation and restored gene expression in PKD1-silenced cell lines. Real-time reverse transcription-polymerase chain reaction analysis of 96 paired clinical primary gastric cancer samples revealed that 59% of the analyzed tumors had a >2-fold decrease in PKD1 expression compared with each normal-appearing tissue and that this downregulation of PKD1 expression was significantly correlated with increased methylation. We also observed a gradual increase in the level of promoter methylation of PKD1 in aging, normal-appearing mucosal tissues, suggesting that PKD1 methylation may be one of the earliest events that predispose an individual to gastric cancer. PKD1 expression was required for directional migration of gastric cancer cells. Furthermore, knock down of PKD1 by RNA interference promoted the invasiveness of cell lines that expressed PKD1 at relatively high levels. Based on these results, we propose that PKD1 is frequently silenced by epigenetic regulation, which plays a role in cell migration and metastasis in gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18283041     DOI: 10.1093/carcin/bgm291

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  45 in total

Review 1.  Protein kinase D as a potential new target for cancer therapy.

Authors:  Courtney R LaValle; Kara M George; Elizabeth R Sharlow; John S Lazo; Peter Wipf; Q Jane Wang
Journal:  Biochim Biophys Acta       Date:  2010-05-24

2.  Inducible silencing of protein kinase D3 inhibits secretion of tumor-promoting factors in prostate cancer.

Authors:  Courtney R LaValle; Liyong Zhang; Shuping Xu; Julie L Eiseman; Q Jane Wang
Journal:  Mol Cancer Ther       Date:  2012-04-24       Impact factor: 6.261

3.  [Role of protein kinase D1 in regulating the growth, apoptosis and drug sensitivity of oral squamous carcinoma cells].

Authors:  Jing-Nan Wang; Ya-Ping Fan; Jiao Chen; Yun Feng; Bo-Miao Cui; Xiao-Ying Li; Li-Wei Wang; Hong-Li Chen; Ping Zhang; Hong-Kun Wu
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2019-12-01

4.  Pathway-BasedFeature Selection Algorithm for Cancer Microarray Data.

Authors:  Nirmalya Bandyopadhyay; Tamer Kahveci; Steve Goodison; Y Sun; Sanjay Ranka
Journal:  Adv Bioinformatics       Date:  2010-03-03

5.  Protein kinase D2 is a novel regulator of glioblastoma growth and tumor formation.

Authors:  Ninel Azoitei; Alexander Kleger; Nina Schoo; Dietmar Rudolf Thal; Cornelia Brunner; Ganesh Varma Pusapati; Alina Filatova; Felicitas Genze; Peter Möller; Til Acker; Rainer Kuefer; Johan Van Lint; Heinrich Baust; Guido Adler; Thomas Seufferlein
Journal:  Neuro Oncol       Date:  2011-07       Impact factor: 12.300

6.  Neuregulin mediates F-actin-driven cell migration through inhibition of protein kinase D1 via Rac1 protein.

Authors:  Heike Döppler; Ligia I Bastea; Tim Eiseler; Peter Storz
Journal:  J Biol Chem       Date:  2012-11-12       Impact factor: 5.157

7.  PKD controls αvβ3 integrin recycling and tumor cell invasive migration through its substrate Rabaptin-5.

Authors:  Claudine Christoforides; Elena Rainero; Kristin K Brown; Jim C Norman; Alex Toker
Journal:  Dev Cell       Date:  2012-09-11       Impact factor: 12.270

8.  Protein kinase d as a potential chemotherapeutic target for colorectal cancer.

Authors:  Ning Wei; Edward Chu; Peter Wipf; John C Schmitz
Journal:  Mol Cancer Ther       Date:  2014-03-14       Impact factor: 6.261

Review 9.  Functional and therapeutic significance of protein kinase D enzymes in invasive breast cancer.

Authors:  Nisha Durand; Sahra Borges; Peter Storz
Journal:  Cell Mol Life Sci       Date:  2015-08-08       Impact factor: 9.261

10.  Protein kinase D1 regulates matrix metalloproteinase expression and inhibits breast cancer cell invasion.

Authors:  Tim Eiseler; Heike Döppler; Irene K Yan; Steve Goodison; Peter Storz
Journal:  Breast Cancer Res       Date:  2009-02-25       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.